AstraZeneca’s vision in Oncology is to help patients by redefining the cancer-treatment paradigm. We have brought four new compounds to patients in the last 5 years. We have a broad pipeline of next-generation medicines focused on the following disease areas - breast, ovarian, lung, GI/GU, and hematological cancers. These are being targeted through four key platforms - immunotherapy, the genetic drivers of cancer and resistance, DNA damage response, and antibody drug conjugates, underpinned by personalized healthcare and biomarker technologies.
This role will be supporting the Las Vegas/Utah territory. You will be responsible for selling, maintaining and documenting all sales activities for the AstraZeneca Oncology GI portfolio of products to physicians in private practice, in group practices, in hospital settings, and Oncology residency and fellowship programs within a defined geographic territory. You will be responsible for calling on all members of the GI tumor MDT, including: medical oncologists, radiation oncologists, pulmonologists, thoracic/cardio-thoracic surgeons, pathologists, NPs, oncology nurses, nurse navigators, pharmacists. Work with Regional Account Director, Oncology Business Managers and OAS counterparts to develop and direct sales strategies at key accounts assigned in the territory.
You will be responsible for positioning AstraZeneca as a leader in Oncology commitment through development of long term relationships with Key Customers and maintaining a high level of clinical expertise by consistently utilizing all available medical information resources. You will also develop and implement clinical sales presentations to groups of healthcare personnel, as well as maximize key physician contact by networking within accounts and at all medical meetings.
Responsibilities
Account Planning
Engagement and Facilitation
Clinical Education
Deliver upstream compliant education regarding diagnosis, treatment, and/or patient management (beyond product) utilizing approved materials
Together, as ambitious experts, we’re building the future and leading the next wave of transformation for our patients, business, and Oncology.